These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35943058)

  • 1. Gray Matter Volume Loss in Proposed Brain-First and Body-First Parkinson's Disease Subtypes.
    Banwinkler M; Dzialas V; ; Hoenig MC; van Eimeren T
    Mov Disord; 2022 Oct; 37(10):2066-2074. PubMed ID: 35943058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric Dopaminergic Dysfunction in Brain-First versus Body-First Parkinson's Disease Subtypes.
    Knudsen K; Fedorova TD; Horsager J; Andersen KB; Skjærbæk C; Berg D; Schaeffer E; Brooks DJ; Pavese N; Van Den Berge N; Borghammer P
    J Parkinsons Dis; 2021; 11(4):1677-1687. PubMed ID: 34334424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical Macro- and Microstructural Changes in Parkinson's Disease with Probable Rapid Eye Movement Sleep Behavior Disorder.
    Pardo J; Montal V; Campabadal A; Oltra J; Uribe C; Roura I; Bargalló N; Martí MJ; Compta Y; Iranzo A; Fortea J; Junqué C; Segura B
    Mov Disord; 2024 May; 39(5):814-824. PubMed ID: 38456361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gray matter volume alterations in de novo Parkinson's disease: A mediational role in the interplay between sleep quality and anxiety.
    He G; Huang X; Sun H; Xing Y; Gu S; Ren J; Liu W; Lu M
    CNS Neurosci Ther; 2024 Jul; 30(7):e14867. PubMed ID: 39031989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease.
    Fiorenzato E; Antonini A; Bisiacchi P; Weis L; Biundo R
    Mov Disord; 2021 Oct; 36(10):2303-2313. PubMed ID: 34124799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in brain atrophy and cognitive impairment in Parkinson's disease patients with and without probable rapid eye movement sleep behavior disorder.
    Oltra J; Segura B; Uribe C; Monté-Rubio GC; Campabadal A; Inguanzo A; Pardo J; Marti MJ; Compta Y; Valldeoriola F; Iranzo A; Junque C
    J Neurol; 2022 Mar; 269(3):1591-1599. PubMed ID: 34345972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactive effect of orthostatic hypotension on gray matter atrophy associated with hyposmia and RBD in de novo Parkinson's disease.
    Shiraishi T; Yoshimaru D; Umehara T; Ozawa M; Omoto S; Okumura M; Kokubu T; Takahashi J; Sato T; Onda A; Komatsu T; Sakai K; Mitsumura H; Murakami H; Okano HJ; Iguchi Y
    J Neurol; 2023 Dec; 270(12):5924-5934. PubMed ID: 37626243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study.
    Horsager J; Andersen KB; Knudsen K; Skjærbæk C; Fedorova TD; Okkels N; Schaeffer E; Bonkat SK; Geday J; Otto M; Sommerauer M; Danielsen EH; Bech E; Kraft J; Munk OL; Hansen SD; Pavese N; Göder R; Brooks DJ; Berg D; Borghammer P
    Brain; 2020 Oct; 143(10):3077-3088. PubMed ID: 32830221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate Detection of α-Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) Cohort.
    Concha-Marambio L; Weber S; Farris CM; Dakna M; Lang E; Wicke T; Ma Y; Starke M; Ebentheuer J; Sixel-Döring F; Muntean ML; Schade S; Trenkwalder C; Soto C; Mollenhauer B
    Mov Disord; 2023 Apr; 38(4):567-578. PubMed ID: 36781413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid eye movement sleep behaviour disorder and striatal dopamine depletion in patients with Parkinson's disease.
    Chung SJ; Lee Y; Lee JJ; Lee PH; Sohn YH
    Eur J Neurol; 2017 Oct; 24(10):1314-1319. PubMed ID: 28782870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson's disease.
    Jenkins PO; Roussakis AA; De Simoni S; Bourke N; Fleminger J; Cole J; Piccini P; Sharp D
    J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):631-637. PubMed ID: 32381639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
    Meles SK; Vadasz D; Renken RJ; Sittig-Wiegand E; Mayer G; Depboylu C; Reetz K; Overeem S; Pijpers A; Reesink FE; van Laar T; Heinen L; Teune LK; Höffken H; Luster M; Kesper K; Adriaanse SM; Booij J; Leenders KL; Oertel WH
    Mov Disord; 2017 Oct; 32(10):1482-1486. PubMed ID: 28734065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease.
    Pagano G; Yousaf T; Wilson H; Niccolini F; Polychronis S; Chaudhuri KR; Politis M
    Eur J Neurol; 2018 Feb; 25(2):307-312. PubMed ID: 29078029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
    Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
    Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain atrophy in Parkinson's disease with polysomnography-confirmed REM sleep behavior disorder.
    Rahayel S; Gaubert M; Postuma RB; Montplaisir J; Carrier J; Monchi O; Rémillard-Pelchat D; Bourgouin PA; Panisset M; Chouinard S; Joubert S; Gagnon JF
    Sleep; 2019 Jun; 42(6):. PubMed ID: 30854555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tract-Based Spatial Statistics Reveal Lower White Matter Integrity Specific to Idiopathic Rapid Eye Movement Sleep Behavior Disorder as a Proxy for Prodromal Parkinson's Disease.
    Ohlhauser L; Smart CM; Gawryluk JR
    J Parkinsons Dis; 2019; 9(4):723-731. PubMed ID: 31498130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Gastric Contraction in Rapid-Eye-Movement Sleep Behavior Disorder and De Novo Parkinson's Disease.
    Oertel WH; Paule E; Hasemann T; Sittig E; Belke M; Unger MM; Mayer G; Werner R; Jansen A; Pape H; Höglinger GU; Vadasz D; Müller HH; Knake S; Janzen A
    Mov Disord; 2024 Jan; 39(1):53-63. PubMed ID: 37955157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease.
    Murtomäki K; Mertsalmi T; Jaakkola E; Mäkinen E; Levo R; Nojonen T; Eklund M; Nuuttila S; Lindholm K; Pekkonen E; Joutsa J; Noponen T; Ihalainen T; Kaasinen V; Scheperjans F
    Mov Disord; 2022 Jun; 37(6):1284-1289. PubMed ID: 35274368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic rapid eye movement sleep behavior disorder in Japan: An observational study.
    Nishikawa N; Murata M; Hatano T; Mukai Y; Saitoh Y; Sakamoto T; Hanakawa T; Kamei Y; Tachimori H; Hatano K; Matsuda H; Taruno Y; Sawamoto N; Kajiyama Y; Ikenaka K; Kawabata K; Nakamura T; Iwaki H; Kadotani H; Sumi Y; Inoue Y; Hayashi T; Ikeuchi T; Shimo Y; Mochizuki H; Watanabe H; Hattori N; Takahashi Y; Takahashi R;
    Parkinsonism Relat Disord; 2022 Oct; 103():129-135. PubMed ID: 36113390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional changes of brain structure during progression of idiopathic Parkinson's disease - A longitudinal study using deformation based morphometry.
    Pieperhoff P; Südmeyer M; Dinkelbach L; Hartmann CJ; Ferrea S; Moldovan AS; Minnerop M; Diaz-Pier S; Schnitzler A; Amunts K
    Cortex; 2022 Jun; 151():188-210. PubMed ID: 35439717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.